YouTube 
Apple Podcasts 
Spotify 
RSS Feed 
Pandora 
PlayerFM 
Podcast Addict 
TuneIn 
Deezer 
iHeartRadio 
Castbox 
Amazon Music 
PocketCasts 
Podchaser Biting Back at Ticks and Christina Applegate’s Mystery Illness
Key Takeaways
- Phase three trial results for a new Lyme disease vaccine offer promising news for preventative care as tick-borne illnesses continue to rise.
- A new once-monthly olanzapine injection provides an alternative long-acting treatment option for patients managing schizophrenia.
- Christina Applegate recently discussed her medical journey, highlighting why she believes her initial multiple sclerosis diagnosis was incorrect.
- Recent research explores the potential link between early-life education reforms in the UK and long-term dementia risk.
- Data from the UK suggests that GLP-1 receptor agonists may have an unexpected impact on patient drinking habits and alcohol consumption.
Friday, October 30, 2026
In today's episode, Dr. Jennifer Lincoln (@drjenniferlincoln) & Eva Johnson cover full phase three results for a Lyme disease vaccine, and Psychiatry Boot Camp host Dr. Mark Mullen pays a visit. They break down a new once monthly olanzapine shot for schizophrenia. Plus: a dementia study built on a 1972 British school reform, why Christina Applegate says her MS diagnosis was wrong, and GLP-1 drugs may affect drinking habits in the UK.
Thank you to guest anchor Dr. Mark Mullen! Check out his podcast Psychiatry Boot Camp, available every other Monday on YouTube and all your favorite podcast apps. To learn more, visit psychiatrybootcamp.com
Coverage Timeline:
(0:00) Intro
(1:26) Lyme Disease Vaccine
(3:31) Vaccine Safety & History
(5:07) Schizophrenia Treatment
(8:26) School & Dementia
Have a story, think we missed something, want to say hi, or curious to learn about the Medlines team? Visit www.medlinespod.com or email medlines@human-content.com.
Sources & Media Attributions for Today's Episode Available At: www.medlinespod.com/sources
Medlines is a Human Content Production
Frequently Asked Questions
What did Christina Applegate say about her MS diagnosis?
Christina Applegate opened up about her ongoing health struggles and questioned the accuracy of her initial multiple sclerosis diagnosis, bringing more awareness to diagnostic challenges in neurology.
What are the latest updates on the Lyme disease vaccine?
Recent updates cover the full phase three trial results for a candidate Lyme disease vaccine, offering a potential new tool to combat tick-borne illnesses.
How does the new once-monthly olanzapine shot work for schizophrenia?
The newly discussed once-monthly olanzapine injection provides a long-acting treatment option designed to improve medication adherence and stability for patients with schizophrenia.
Do GLP-1 drugs affect drinking habits?
Recent observations and data emerging from the UK suggest that GLP-1 receptor agonist medications may influence and potentially reduce alcohol consumption in some individuals.